0 of 8 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 8 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 80% to continue. Please click the link below to re-take the quiz
1. How confident are you in the management of patients with diabetes in your practice?
2. New guidelines from the ADA/EASD for T2DM recommend initiating basal insulin as the first injectable if the patient has:
3. Which of the following is a recommended strategy for facilitating patient acceptance of insulin?
4. Fixed-ratio combinations that contain a GLP-1 RA and a longer-acting insulin (24–42 hours) are effective for reducing A1c by 1.7%–1.9%, lowering __________, and minimizing hypoglycemia.
5. Roberta is a 62-year-old patient who was diagnosed with T2DM 1 year ago. She has been treated with metformin and a biguanide, but her A1c is still above 10%. She also has a BMI of 34, hypertension, a history of heart disease, and she is resistant to using insulin. While any of the options below might be a good treatment choice, which would be the BEST option for encouraging adoption of insulin and reducing A1c, body weight, and potential macrovascular complications?
6. Which of the following is false? Insulin glargine U-300 and insulin degludec have PK/PD profiles that are close to endogenous basal insulin because they:
7. According to the new ADA/EASD guidelines, which class of agents should be used as adjunctive treatment with insulin to more effectively individualize treatment for patients with T2DM and atherosclerotic cardiovascular disease?
8. Diabetes self-management education and support (DSME/S) is an effective patient-centered approach for individualizing therapy, improving A1c, and eliminating the barriers to initiating insulin and insulin combinations. DSME/S also: